Product
Fosmanogepix
Aliases
PF-07842805
3 clinical trials
5 indications
Indication
Liver ImpairmentIndication
CandidemiaIndication
CandidiasisIndication
InvasiveIndication
Invasive Fungal InfectionsClinical trial
A Phase 1, Open-label, Single-dose, Parallel Cohort Study to Assess the Pharmacokinetics and Safety of Fosmanogepix (PF 07842805) in Adult Participants With Varying Degrees of Hepatic ImpairmentStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
An Interventional Efficacy and Safety Phase 3 Double-blind 2-arm Study to Investigate IV Followed by Oral Fosmanogepix Compared With IV Caspofungin Followed by Oral Fluconazole in Adult Participants With Candidemia and/or Invasive CandidiasisStatus: Not yet recruiting, Estimated PCD: 2027-07-15